Published on 05 August 2013
Italy’s final position paper on biosimilars and new price and reimbursement pathway
Author(s): Gianluigi Casadei, MD
AIFA, biosimilars, market access, position paper, pricing, reimbursement
DOI: 10.5639/gabij.2013.0203.033
16.615 views